{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:47:17Z","timestamp":1780386437558,"version":"3.54.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC 2016\/17"],"award-info":[{"award-number":["RC 2016\/17"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.pcad.2018.07.020","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T15:31:01Z","timestamp":1532187061000},"page":"328-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Precise Therapy for Thoracic Aortic Aneurysm in Marfan Syndrome: A Puzzle Nearing Its Solution"],"prefix":"10.1016","volume":"61","author":[{"given":"Erica","family":"Rurali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca Lorenzo","family":"Perrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Assunta","family":"Pilato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Gaetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Pompilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2018.07.020_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13023-015-0369-8","article-title":"Prevalence, incidence, and age at diagnosis in Marfan syndrome","volume":"10","author":"Groth","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pcad.2018.07.020_bb0010","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1253\/circj.CJ-13-0584","article-title":"Clinical features differ substantially between Caucasian and Asian populations of Marfan syndrome","volume":"77","author":"Franken","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.pcad.2018.07.020_bb0015","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan's syndrome","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijcard.2015.03.423","article-title":"Molecular pathogenesis of Marfan syndrome","volume":"187","author":"Ramachandra","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0025","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI23701","article-title":"Marfan syndrome and mitral valve prolapse","volume":"114","author":"Weyman","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2018.07.020_bb0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12265-011-9314-y","article-title":"Mitral valve disease in Marfan syndrome and related disorders","volume":"4","author":"Judge","year":"2011","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.pcad.2018.07.020_bb0035","doi-asserted-by":"crossref","first-page":"e1059","DOI":"10.1542\/peds.2013-2063","article-title":"Health supervision for children with Marfan syndrome","volume":"132","author":"Tinkle","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcad.2018.07.020_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pcad.2018.07.020_bb0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/humu.10249","article-title":"Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database","volume":"22","author":"Collod-Beroud","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pcad.2018.07.020_bb0050","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1093\/eurheartj\/ehw154","article-title":"The search for genotype\/phenotype correlation in Marfan syndrome: to be or not to be?","volume":"37","author":"Loeys","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2018.07.020_bb0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/jmedgenet-2016-103996","article-title":"Homozygous and compound heterozygous mutations in the FBN1 gene: unexpected findings in molecular diagnosis of Marfan syndrome","volume":"54","author":"Arnaud","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0060","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.ejhg.5201865","article-title":"Homozygosity for a FBN1 missense mutation: clinical and molecular evidence for recessive Marfan syndrome","volume":"15","author":"de Vries","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaapos.2013.11.012","article-title":"Results of fibrillin-1 gene analysis in children from inbred families with lens subluxation","volume":"18","author":"Khan","year":"2014","journal-title":"J AAPOS"},{"key":"10.1016\/j.pcad.2018.07.020_bb0070","doi-asserted-by":"crossref","first-page":"E1915","DOI":"10.1002\/humu.21372","article-title":"The clinical spectrum of missense mutations of the first aspartic acid of cbEGF-like domains in fibrillin-1 including a recessive family","volume":"31","author":"Hilhorst-Hofstee","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pcad.2018.07.020_bb0075","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/cge.12073","article-title":"Homozygosity for a FBN1 missense mutation causes a severe Marfan syndrome phenotype","volume":"84","author":"Hogue","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0080","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/hrt.2010.212100","article-title":"The translational science of Marfan syndrome","volume":"97","author":"Jondeau","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2018.07.020_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00018-016-2324-9","article-title":"Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall","volume":"74","author":"Perrucci","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pcad.2018.07.020_bb0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.108.841981","article-title":"Circulating transforming growth factor-beta in Marfan syndrome","volume":"120","author":"Matt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2018.07.020_bb0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pcad.2018.07.020_bb0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","volume":"114","author":"Judge","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2018.07.020_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2044-5040-1-19","article-title":"Role of TGF-beta signaling in inherited and acquired myopathies","volume":"1","author":"Burks","year":"2011","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.pcad.2018.07.020_bb0115","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI200422715","article-title":"TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome","volume":"114","author":"Ng","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2018.07.020_bb0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/520125","article-title":"Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study","volume":"81","author":"Faivre","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1399-0004.1999.550207.x","article-title":"Novel exon skipping mutation in the fibrillin-1 gene: two 'hot spots' for the neonatal Marfan syndrome","volume":"55","author":"Booms","year":"1999","journal-title":"Clin Genet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13023-017-0754-6","article-title":"The importance of genotype-phenotype correlation in the clinical management of Marfan syndrome","volume":"13","author":"Becerra-Munoz","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pcad.2018.07.020_bb0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial outcome of Losartan therapy depends on type of FBN1 mutation in Marfan syndrome","volume":"8","author":"Franken","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCGENETICS.115.001040","article-title":"Potential phenotype-genotype correlation in Marfan syndrome: when less is more?","volume":"8","author":"Dietz","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0145","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/heartjnl-2017-311513","article-title":"Genotype-phenotype correlations in Marfan syndrome","volume":"103","author":"Landis","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2018.07.020_bb0150","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/eurheartj\/ehv739","article-title":"Genotype impacts survival in Marfan syndrome","volume":"37","author":"Franken","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2018.07.020_bb0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ejhg.2010.174","article-title":"The clinical spectrum of complete FBN1 allele deletions","volume":"19","author":"Hilhorst-Hofstee","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0160","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/hmg\/ddg241","article-title":"Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?","volume":"12","author":"Hutchinson","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pcad.2018.07.020_bb0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0002-9149(00)80066-1","article-title":"Life expectancy in the Marfan syndrome","volume":"75","author":"Silverman","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/hrt.2008.160515","article-title":"Marfan syndrome: 30 years of research equals 30 years of additional life expectancy","volume":"95","author":"Pyeritz","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2018.07.020_bb0175","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1161\/CIR.0b013e3181d47d48","volume":"121","author":"Hiratzka","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2018.07.020_bb0180","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2018.07.020_bb0185","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/thx.23.4.338","article-title":"A technique for complete replacement of the ascending aorta","volume":"23","author":"Bentall","year":"1968","journal-title":"Thorax"},{"key":"10.1016\/j.pcad.2018.07.020_bb0190","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-5223(19)34942-6","article-title":"An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta","volume":"103","author":"David","year":"1992","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pcad.2018.07.020_bb0195","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/hrt.2010.210286","article-title":"Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis","volume":"97","author":"Benedetto","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2018.07.020_bb0200","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/heartjnl-2013-304709","article-title":"Diagnosis and treatment of Marfan syndrome: an update","volume":"100","author":"Radke","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2018.07.020_bb0205","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2018.07.020_bb0210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jtcvs.2015.10.068","article-title":"Long-term outcomes of aortic root operations for Marfan syndrome: a comparison of Bentall versus aortic valve-sparing procedures","volume":"151","author":"Price","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pcad.2018.07.020_bb0215","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1136\/heartjnl-2013-305132","article-title":"Surgical management of aortic root disease in Marfan syndrome and other congenital disorders associated with aortic root aneurysms","volume":"100","author":"Treasure","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2018.07.020_bb0220","article-title":"Implantation of an individually computer-designed and manufactured external support for the Marfan aortic root","volume":"2013","author":"Pepper","year":"2013","journal-title":"Multimed Man Cardiothorac Surg"},{"key":"10.1016\/j.pcad.2018.07.020_bb0225","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/heartjnl-2013-304913","volume":"100","author":"Treasure","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2018.07.020_bb0230","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ejcts\/ezu415","article-title":"Histology of a Marfan aorta 4.5 years after personalized external aortic root support","volume":"48","author":"Pepper","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pcad.2018.07.020_bb0235","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijcard.2015.06.015","article-title":"Effect of personalized external aortic root support on aortic root motion and distension in Marfan syndrome patients","volume":"197","author":"Izgi","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0240","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.jbiomech.2016.05.011","article-title":"Effects of aortic root motion on wall stress in the Marfan aorta before and after personalised aortic root support (PEARS) surgery","volume":"49","author":"Singh","year":"2016","journal-title":"J Biomech"},{"key":"10.1016\/j.pcad.2018.07.020_bb0245","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.athoracsur.2015.05.117","article-title":"The potential of personalized external aortic root support (PEARS) to restore and maintain aortic valve competence","volume":"100","author":"Treasure","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pcad.2018.07.020_bb0250","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jtcvs.2017.03.037","article-title":"Plan, scan, model, print, manufacture, and implant personalized external aortic root support (PEARS)","volume":"154","author":"Treasure","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pcad.2018.07.020_bb0255","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/bjsports-2014-306440rep","article-title":"Marfan syndrome, inherited aortopathies and exercise: what is the right answer?","volume":"50","author":"Cheng","year":"2016","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.pcad.2018.07.020_bb0260","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrcardio.2015.95","article-title":"Aortic disease: Losartan versus atenolol in the Marfan aorta-how to treat?","volume":"12","author":"Franken","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0265","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijcard.2016.04.186","article-title":"The effect of losartan on progressive aortic dilatation in patients with Marfan's syndrome: a meta-analysis of prospective randomized clinical trials","volume":"217","author":"Gao","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0270","first-page":"123","article-title":"A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment","volume":"129","author":"Halpern","year":"1971","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.pcad.2018.07.020_bb0275","article-title":"Beta-blockers for preventing aortic dissection in Marfan syndrome","volume":"11","author":"Koo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pcad.2018.07.020_bb0280","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2018.07.020_bb0285","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0002-9149(94)90762-5","article-title":"Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome","volume":"74","author":"Salim","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0290","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0002-9149(99)00101-0","article-title":"Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome","volume":"83","author":"Rossi-Foulkes","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0295","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjcard.2006.08.048","article-title":"Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome","volume":"99","author":"Ladouceur","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpeds.2006.09.003","article-title":"Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome","volume":"150","author":"Selamet Tierney","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.pcad.2018.07.020_bb0305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/heart.88.1.97","article-title":"Management of Marfan syndrome","volume":"88","author":"Dean","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2018.07.020_bb0310","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cjca.2015.11.003","article-title":"Recent clinical drug trials evidence in Marfan syndrome and clinical implications","volume":"32","author":"Singh","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0315","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1161\/CIRCULATIONAHA.107.693523","article-title":"Medical management of Marfan syndrome","volume":"117","author":"Keane","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2018.07.020_bb0320","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2459\/JCM.0b013e3283232a45","article-title":"Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations","volume":"10","author":"Gambarin","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.pcad.2018.07.020_bb0325","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1074\/jbc.M806962200","article-title":"p38 MAPK is an early determinant of promiscuous Smad2\/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice","volume":"284","author":"Carta","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pcad.2018.07.020_bb0330","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1007\/s10439-016-1616-4","article-title":"Losartan attenuates degradation of aorta and lung tissue micromechanics in a mouse model of severe Marfan syndrome","volume":"44","author":"Lee","year":"2016","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.pcad.2018.07.020_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107221","article-title":"No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice","volume":"9","author":"Franken","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pcad.2018.07.020_bb0340","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.drudis.2014.09.022","article-title":"Angiotensin receptor blockers: a panacea for Marfan syndrome and related disorders?","volume":"20","author":"Loeys","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pcad.2018.07.020_bb0345","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2018.07.020_bb0350","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3349\/ymj.2016.57.1.81","article-title":"The beneficial effect of Renin-Angiotensin-Aldosterone system blockade in Marfan syndrome patients after aortic root replacement","volume":"57","author":"Lee","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.pcad.2018.07.020_bb0355","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to beta-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pcad.2018.07.020_bb0360","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan Sartan: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Milleron","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2018.07.020_bb0365","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2018.07.020_bb0370","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/heartjnl-2013-304946","article-title":"Retrospective analysis of the effect of angiotensin II receptor blocker versus beta-blocker on aortic root growth in paediatric patients with Marfan syndrome","volume":"100","author":"Mueller","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2018.07.020_bb0375","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.amjcard.2013.06.019","article-title":"Usefulness of losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome","volume":"112","author":"Pees","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0380","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2018.07.020_bb0385","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1358863X15569868","article-title":"Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome","volume":"20","author":"Bhatt","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.pcad.2018.07.020_bb0390","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ijcard.2014.11.082","article-title":"A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes","volume":"179","author":"Sandor","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0395","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/hrt.2006.109454","article-title":"Medical treatment of Marfan syndrome: a time for change","volume":"94","author":"Williams","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2018.07.020_bb0400","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08648","article-title":"A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome","volume":"4","author":"Doyle","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.pcad.2018.07.020_bb0405","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","article-title":"Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1","volume":"96","author":"Pereira","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2018.07.020_bb0410","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1074\/jbc.M511599200","article-title":"Fibrillins 1 and 2 perform partially overlapping functions during aortic development","volume":"281","author":"Carta","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pcad.2018.07.020_bb0415","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/ATVBAHA.114.305150","article-title":"Dimorphic effects of transforming growth factor-beta signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome","volume":"35","author":"Cook","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2018.07.020_bb0420","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jvs.2007.09.016","article-title":"Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome","volume":"47","author":"Xiong","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pcad.2018.07.020_bb0425","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI0215334","article-title":"Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms","volume":"110","author":"Longo","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2018.07.020_bb0430","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jtcvs.2009.10.039","article-title":"Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome","volume":"140","author":"Yang","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pcad.2018.07.020_bb0435","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1161\/CIRCULATIONAHA.110.012187","article-title":"Pravastatin reduces Marfan aortic dilation","volume":"124","author":"McLoughlin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2018.07.020_bb0440","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1749-6632.2012.06493.x","article-title":"Are we ignoring the dilated thoracic aorta?","volume":"1254","author":"Castellano","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pcad.2018.07.020_bb0445","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pcad.2018.07.020_bb0450","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/embj.201387098","article-title":"iPS cells: a game changer for future medicine","volume":"33","author":"Inoue","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.pcad.2018.07.020_bb0455","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1073\/pnas.1113442109","article-title":"Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells","volume":"109","author":"Quarto","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2018.07.020_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007118","article-title":"Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts","volume":"4","author":"Byrne","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pcad.2018.07.020_bb0465","series-title":"ESC2015","article-title":"Modeling Marfan syndrome with induced pluripotent stem cell-derived vascular smooth muscle cells","author":"Saito","year":"2015"},{"key":"10.1016\/j.pcad.2018.07.020_bb0470","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng.3723","article-title":"An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death","volume":"49","author":"Granata","year":"2016","journal-title":"Nat Genet"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062018301531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062018301531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T23:13:38Z","timestamp":1751757218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062018301531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":94,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0033062018301531"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2018.07.020","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precise Therapy for Thoracic Aortic Aneurysm in Marfan Syndrome: A Puzzle Nearing Its Solution","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2018.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}